| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.01B | 6.79B | 6.87B | 7.05B | 6.92B | 6.59B |
| Gross Profit | 2.88B | 2.76B | 2.60B | 2.10B | 2.65B | 2.50B |
| EBITDA | 1.99B | 1.57B | 2.89B | 3.46B | 2.92B | 2.81B |
| Net Income | 1.61B | 1.56B | 1.56B | 1.53B | 1.31B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 27.65B | 27.82B | 27.88B | 28.03B | 27.94B | 27.78B |
| Cash, Cash Equivalents and Short-Term Investments | 2.95B | 2.85B | 4.28B | 2.84B | 4.85B | 4.05B |
| Total Debt | 4.10B | 3.87B | 5.20B | 6.13B | 6.91B | 7.33B |
| Total Liabilities | 6.00B | 6.27B | 7.61B | 8.65B | 9.72B | 10.87B |
| Stockholders Equity | 20.66B | 20.44B | 19.33B | 18.42B | 17.32B | 16.06B |
Cash Flow | ||||||
| Free Cash Flow | 1.77B | 1.85B | 1.37B | 1.33B | 1.72B | 1.18B |
| Operating Cash Flow | 2.70B | 2.72B | 2.42B | 2.39B | 2.43B | 2.51B |
| Investing Cash Flow | -1.53B | -1.37B | -789.92M | -2.74B | -464.68M | -1.86B |
| Financing Cash Flow | -1.69B | -1.62B | -1.57B | -1.41B | -1.09B | -264.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$63.69B | 7.14 | 11.51% | 5.34% | 1.02% | 0.36% | |
75 Outperform | HK$20.63B | 6.93 | 7.93% | 3.47% | 6.08% | 5.81% | |
73 Outperform | HK$66.33B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
73 Outperform | HK$38.71B | 9.45 | 3.62% | 3.23% | 8.66% | 53.27% | |
69 Neutral | HK$4.43B | 3.20 | 4.48% | 6.69% | -14.81% | -3.39% | |
67 Neutral | HK$20.79B | 7.64 | 4.96% | 4.97% | 10.25% | -9.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |